cyclopentane has been researched along with Neuroendocrine Tumors in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson-Sand, H; Caramuta, S; Fotouhi, O; Ghaderi, M; Juhlin, CC; Kharaziha, P; Kjellin, H; Kjellman, M; Larsson, C; Orre, LM; Pan, Y; Vesterlund, M; Yousef, A; Zedenius, J | 1 |
1 other study(ies) available for cyclopentane and Neuroendocrine Tumors
Article | Year |
---|---|
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
Topics: Aged; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cyclopentanes; Female; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; NEDD8 Protein; Neuroendocrine Tumors; Proliferating Cell Nuclear Antigen; Proteomics; Pyrimidines; RNA, Small Interfering; Ubiquitins | 2019 |